Experience

Molecular Products

• United Kingdom
• Chemical Manufacturing
• 1 - 100 Employee

• Finance Director

  • Nov 2013 - Present

  £25m international business producing critical air products (CO2 absorption, O2 production and filtration products). 2016Assisted in the preparation of the privately owned business (in which BGF had a minority stake) sale, including a vendor due diligence process, data room preparation and presentations. The business was successfully sold by an auction process in December 2016 to a US based Venture Capitalist. 2015Co-ordinating with lawyers, accountants and banks, I lead the formation of Molecular Products Group India Pvt Limited and Molecular Products Australia PTY Limited.2014Successful negotiation for investment from Business Growth Fund (BGF).

• Financial Controller

  • Sep 2009 - Nov 2013

  Initially appointed as Molecular Products Limited Financial Controller, responsible for all aspects of UK companies accounts. Also responsible for consolidation of Molecular Group monthly management accounts and year end statutory accounts. Subsequently appointed Company Secretary and the responsibility of reporting directly to Group Board. Took the lead on restructuring finances including, change of bank and preparation for future investment. Following sucessful negotiations I was promoted to Molecular Products Limited Finance Director.



Tazaki Foods Ltd

• United Kingdom
• Food and Beverage Services
• 1 - 100 Employee

• Financial Controller

  • Jan 2007 - Sep 2009



EVOBUS (UK) LIMITED

• United Kingdom
• Motor Vehicle Manufacturing
• 1 - 100 Employee

• Financial Controller

  • 1998 - 2007

  A member of the DaimlerChrsyler Group, EvoBus (UK)Ltd was renamed and restructured to merge three subsidiaries. At that time, I was employed to set up a uniform accounting (SAP r3) and finance team along with relocating the accounting function from Lincoln and Milton Keynes to Coventry. Following successful relocation and integration 'normal' financial reporting included the monitoring of intercompany transactions for Germany and reports compliant to USGAAP and subsequently IFRS.